	CAIX-targeted PET/CT in clear cell renal cell carcinoma: a systematic review of current evidence and clinical perspectives. Minerva Urol Nephrol Garrou F, Sacchetti GM, Leva L, Manfredi M, DE Cillis S, Fiori C. PMID: 42823864 [PubMed - indexed for MEDLINE]
	Simultaneous surgery for NMIBC and BOO: evaluating surgical safety to oncological benefit. Minerva Urol Nephrol Ermi, Aybal HÇ, Yuan CY, Tozsin A, Fiori C, Herrmann T, Aydin A, Ahmed K, Güven S. PMID: 42823863 [PubMed - indexed for MEDLINE]
	Global guidelines for the management of penile cancer: evaluating clinical alignment and methodological rigor. Minerva Urol Nephrol Pandolfo SD, Aveta A, Iossa V, Cilio S, Palmieri A, Russo P, Lasorsa F, Lucarelli G, Siracusano S, Necchi A, Mercinelli C, Castiglione F, Manfredi C, Formisano L, Derweesh IH, Brouwer OR, Autorino R. PMID: 42823862 [PubMed - indexed for MEDLINE]
	Metastatic Bone Disease Is Associated With Longitudinal Muscle Loss and Reduced Survival in Kidney Cancer. J Cachexia Sarcopenia Muscle Poirier JL, Jines ST, Silverman LM, Kambrath AV, Wurtz LD, Zimmers TA, Collier CD. PMID: 42823780 [PubMed - indexed for MEDLINE]
	Refining prostate cancer diagnosis: correlative analysis of Gleason scores and immunohistochemical markers. Diagn Pathol Ao H, Liu Q. PMID: 42823706 [PubMed - indexed for MEDLINE]
	Effect of Acupuncture on Urine Production and Storage in Prostate Cancer Survivors With Nocturia: Exploratory Analysis of a Randomized Clinical Trial. JU Open Plus Booher AG, Mao J, Sandhu J, Ajay D, Carlsson SV, Laudone V, Morris MJ, Liou KT. PMID: 42820187 [PubMed]
	Advances in Exosome Research in Renal Cell Carcinoma: Mechanisms, Biomarkers, and Therapeutic Applications. Int J Nanomedicine Luo J, Wang L, Zhou M, Huang W, Zhang M, He J, Yu B, Chen Z. PMID: 42820075 [PubMed - indexed for MEDLINE]
	Participation and satisfaction of prostate cancer patients on androgen deprivation therapy participating in a virtual supervised group exercise service. BJUI Compass Curtis E, Russell A, Cottrell C, Cowan-Dickie S, Dewhurst S, Kinsella N, Suh YE, Cahill D, Fox L, Van Hemelrijck M, Reid A. PMID: 42819773 [PubMed]
	Surrogacy of intermediate clinical endpoints for overall survival in BCG-naÃ¯ve high-risk non-muscle-invasive bladder cancer. World J Urol Scilipoti P, , Subiela JD, Longoni M, Occhi A, Zaurito P, Tremolada G, Maiorano B, Soria F, Krajewski W, D'Andrea D, Claps F, Del Giudice F, Pichler R, Grobet-Jeandin E, Gallioli A, Afferi L, Mastroianni R, Simone G, Mertens LS, Laukhtina E, Rodriguez Elena JL, Aranda J, Lafuente Puentedura A, Caño Velasco J, Contieri R, Zorzi F, Liguori G, Hurle R, Cirulli GO, Naspro R, Mori K, Marcq G, Radziszewski P, Shariat SF, Gontero P, Rouprêt M, Seisen T, Montorsi F, Briganti A, Pradere B, Moschini M, European Association of Urology -Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. PMID: 42823574 [PubMed - indexed for MEDLINE]
	Circulating tumour DNA and extrachromosomal DNA in prostate and bladder cancer: biology, clinical applications and future perspectives. World J Urol Elmasmoudi J, Merseburger AS. PMID: 42823553 [PubMed - indexed for MEDLINE]
	Prognostic Impact of Diagnostic Delay in Testicular Cancer: A Single-center Mexican Cohort Study With Machine Learning Risk Prediction. Clin Genitourin Cancer Cantellano-Orozco M, Anceno A, Silva-Mendoza CA, Garzón-Ortega VH, Hosseini H, Angulo-Sánchez JR, Magdaleno-Rodríguez DR, Cervantes-Zorrilla R, Martínez-Arroyo C, Fernández-Noyola G, Morales-Montor G, Ortega-González M, Pacheco-Gahbler C. PMID: 42823227 [PubMed - as supplied by publisher]
	Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer. Eur Urol Davis LE, Basourakos SP, Calaway AC. PMID: 42823220 [PubMed - as supplied by publisher]
	Re: Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9Â yr Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial. Eur Urol Gulati R, Etzioni R. PMID: 42823219 [PubMed - as supplied by publisher]
	Reply to Pierre-Etienne Gabriel and Evanguelos Xylinas's Letter to the Editor re: Ding Ding, Lei Qian, Di Jin, et al. Aptamer-based Positron Emission Tomography Imaging Allows Specific Detection of Residual Bladder Cancer: A First-in-Human Study. Eur Urol. 2026;89:93-5. Eur Urol Ding D, Wei W, Chen H, Tan W. PMID: 42823217 [PubMed - as supplied by publisher]
	Re: Active Surveillance Versus Intravesical Bacillus Calmette-GuÃ©rin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.008. Eur Urol , Uleri A, Radziszewski P, Pradere B. PMID: 42823216 [PubMed - as supplied by publisher]
	Real-world Outcomes of First-line Enfortumab Vedotin Plus Pembrolizumab in Elderly Patients With Advanced Urothelial Carcinoma. Anticancer Res Kaneko GO, Igarashi D, Morita M, Tsubota S, Baba Y, Shirotake S. PMID: 42823175 [PubMed - indexed for MEDLINE]
	Structured Symptom Monitoring During Enfortumab Vedotin Plus Pembrolizumab for Advanced or Metastatic Urothelial Carcinoma: Multicenter Retrospective Study. Anticancer Res Wakamiya T, Iwagami S, Enyo N, Shibano S, Nabeshima Y, Deguchi R, Kuwata K, Wada T, Yamashita S, Kohjimoto Y. PMID: 42823162 [PubMed - indexed for MEDLINE]
	Robot-assisted Radical Nephrectomy for Renal Cell Carcinoma With Versus Without Venous Tumor Thrombus. Anticancer Res Yoshino M, Yoshida K, Kobari Y, Fukuda H, Iizuka J, Takagi T. PMID: 42823156 [PubMed - indexed for MEDLINE]
	Primary malignant mesothelioma of the tunica vaginalis presenting as hydrocele: imaging pitfalls. BMJ Case Rep Naidu J, Joseph NG, Mohammed M, Baskaradoss VK. PMID: 42823143 [PubMed - indexed for MEDLINE]
	New and Novel Agents for Advanced Bladder Cancer. Urol Clin North Am Superdock M, Iyer G, Milowsky MI. PMID: 42823054 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 181894

Page 1 of 9095



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy